Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN.

Nephrol Dial Transplant · 2025 · PMC12209846 · PMID 39673454

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Q21: WHAT IS THE PREVALENCE AND THE MANAGEMENT OF ALPORT POST-TRANSPLANT NEPHRITIS OR DE NOVO GBM DISEASE? 21-Statement: While the risk of anti-GBM disease following a kidney transplant for AS without immunosuppressive therapy may be significant, current immunosuppressive treatments reduce this risk to less than 3%.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.